Teva Pharmaceutical Industries ( TEVA +20.23%) had a day on the stock market to remember on Wednesday. The drugmaker 's share ...

(Reuters) -Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered ...

For its third quarter, Crinetics earned $143,000 in revenue, derived fully from a licensing agreement with Japanese ...

Analysts estimate that ARS Pharmaceuticals will report an earnings per share (EPS) of $-0.47. ARS Pharmaceuticals bulls will hope to hear the company announce they've not only beaten that estimate, ...

Now, it’s worth noting Stock Advisor’s total average return is 1,033% — a market-crushing outperformance compared to 193 % ...

On November 3, 2025, Privium Fund Management B.V. reported selling 138,263 shares of Arrowhead Pharmaceuticals ( ARWR 1.57%) ...

Teva shares jumped 12% after Q3 earnings beat estimates, driven by strong branded drug sales led by Austedo and solid guidance for 2025.

Learn more about whether ADMA Biologics, Inc. or BioMarin Pharmaceutical Inc. is a better investment based on AAII's A+ ...

Indian drugmaker Torrent Pharma reported a 30.5% rise in its second-quarter profit on Friday, driven by strong domestic demand for its cardiovascular and anti-diabetic drugs.

Skyrocketing healthcare costs could deliver another blow to the industry’s ongoing quest to boost representation in R&D.

Learn more about whether BioMarin Pharmaceutical Inc. or Ultragenyx Pharmaceutical Inc. is a better investment based on ...